Why the study?
Does end-stage renal disease requiring peritoneal dialysis impair heart rhythm complexity in patients without prior cardiovascular disease?
Does end-stage renal disease requiring peritoneal dialysis impair heart rhythm complexity in patients without prior cardiovascular disease?
Patients undergoing peritoneal dialysis without prior cardiovascular disease exhibit impaired heart rhythm complexity, which can be effectively discriminated using multiscale entropy parameters.
Impaired heart rhythm complexity in peritoneal dialysis patients signals autonomic dysfunction; leaves open its added prognostic value beyond conventional risk factors.
Cardiovascular disease is one of the leading causes of death in patients with advanced renal disease. The objective of this study was to investigate impairments in heart rhythm complexity in patients with end-stage renal disease. We prospectively analyzed 65 patients undergoing peritoneal dialysis (PD) without prior cardiovascular disease and 72 individuals with normal renal function as the control group. Heart rhythm analysis including complexity analysis by including detrended fractal analysis (DFA) and multiscale entropy (MSE) were performed. In linear analysis, the PD patients had a significantly lower standard deviation of normal RR intervals (SDRR) and percentage of absolute differences in normal RR intervals greater than 20 ms (pNN20). Of the nonlinear analysis indicators, scale 5, area under the MSE curve for scale 1 to 5 (area 1-5) and 6 to 20 (area 6-20) were significantly lower than those in the control group. In DFA anaylsis, both DFA α1 and DFA α2 were comparable in both groups. In receiver operating characteristic curve analysis, scale 5 had the greatest discriminatory power for two groups. In both net reclassification improvement model and integrated discrimination improvement models, MSE parameters significantly improved the discriminatory power of SDRR, pNN20, and pNN50. In conclusion, PD patients had worse cardiac complexity parameters. MSE parameters are useful to discriminate PD patients from patients with normal renal function.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: